INNO-GENE SA ZY -10 (WQ3) — Working Capital to Net Assets Ratio
INNO-GENE SA ZY -10 (WQ3) has a Working Capital to Net Assets ratio of 6.9% as of June 2025. Working capital of €1.21 Million (current assets of €8.22 Million minus current liabilities of €7.01 Million) is measured against net assets of €17.55 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See WQ3 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
INNO-GENE SA ZY -10 Working Capital to Net Assets (2021–2024)
This chart shows how INNO-GENE SA ZY -10's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2021 to 2024. As of June 2025, the ratio stands at 6.9%, reflecting working capital of €1.21 Million against net assets of €17.55 Million EUR. For the complete balance sheet picture, see INNO-GENE SA ZY -10 total assets.
Annual Working Capital to Net Assets for INNO-GENE SA ZY -10 (2021–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for INNO-GENE SA ZY -10 from 2021 to 2024, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check INNO-GENE SA ZY -10 liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 9.5% | €1.71 Million | €18.02 Million | €8.07 Million | €6.36 Million | ▲ +7.0 pp |
| 2023 | 2.5% | €61.63K | €2.44 Million | €3.02 Million | €2.95 Million | ▼ -64.0 pp |
| 2022 | 66.5% | €5.36 Million | €8.05 Million | €7.44 Million | €2.08 Million | ▼ -18.9 pp |
| 2021 | 85.5% | €6.71 Million | €7.85 Million | €12.31 Million | €5.60 Million | — |